SCHEMBL6188311

SCHEMBL6188311

O=C(O)CCNC(=O)CCNC(=O)CO

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 3/20 0.56
FAAH O00519 2/20 0.42
CNR1 P21554 2/20 0.42
CNR2 P34972 2/20 0.42
PRMT1 Q99873 1/20 0.41
ITGB3 P05106 4/20 0.40
ITGA2B P08514 3/20 0.40
TSHR P16473 2/20 0.38
KDM4E B2RXH2 2/20 0.37
PLA2G2A P14555 1/20 0.37
HTT P42858 1/20 0.37
KDM6B O15054 1/20 0.37
KDM5C P41229 1/20 0.37
FOLH1 Q04609 1/20 0.37
EGLN1 Q9GZT9 1/20 0.37
PHF8 Q9UPP1 1/20 0.37
KDM2A Q9Y2K7 1/20 0.37
ITGAV P06756 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4811364 0.95 ECE1 (0.60) ECE1FAAHCNR1CNR2PRMT1
SCHEMBL9717431 0.85 ECE1 (0.65) ECE1FAAHCNR1CNR2PRMT1
SCHEMBL8531287 0.82 ECE1 (0.62) ECE1FAAHCNR1CNR2ITGB3
SCHEMBL13465545 0.82 EPHX2 (0.49) FAAHCNR1CNR2PRMT1TSHR
SCHEMBL19607968 0.81 ATM (0.53) ECE1PRMT1TSHRKDM4ELMNA
SCHEMBL6188305 0.81 ECE1 (0.56) ECE1FAAHCNR1CNR2PRMT1
SCHEMBL9717391 0.80 ECE1 (0.60) ECE1FAAHCNR1CNR2PRMT1
SCHEMBL9717382 0.80 ECE1 (0.60) ECE1FAAHCNR1CNR2PRMT1
SCHEMBL9717468 0.79 ECE1 (0.81) ECE1FAAHCNR1CNR2PRMT1
SCHEMBL17951118 0.79 ADRA1A (0.57) ECE1FAAHCNR1CNR2PRMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1521742-A1 DIPHENYLAZETIDINONE DERIVATIVES FOR TREATING DISORDERS OF THE LIPID METABOLISM AstraZeneca AB (SE) 2005-04-13 EP disclosed
WO-2004005247-A1 DIPHENYLAZETIDINONE DERIVATIVES FOR TREATING DISORDERS OF THE LIPID METABOLISM ASTRAZENECA AB (SE) 2004-01-15 WO disclosed